Clinical trial
Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
NCT04331769 is registered in ClinicalTrials.gov with Ancora Heart, Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Randomized Clinical Evaluation of the AccuCinch® Ventricular Restoration System in Patients Who Present With Symptomatic Heart Failure With Reduced Ejection Fraction (HFrEF): The CORCINCH-HF Study
- Lead sponsor
- Ancora Heart, Inc.
- Phase
- Not applicable
- Overall status
- Suspended
- Start date
- December 21, 2020
- Completion date
- December 21, 2030
- Enrollment
- 400 (estimated)
- Sites
- 122
Conditions
As the registry lists them; a condition with its own page is linked.
dilated cardiomyopathy, heart failure with reduced ejection fraction (hfref)